News Articles
Browse our entire archive of news articles, spotlight interviews, and other editorial pieces in one place.
Filters
Novamind Expands Group Therapy Model
Novamind Inc.
Cybin-Sponsored Feasibility Study Using Kernel Flow Technology Currently Recruiting Participants
Cybin Inc.
atai Life Sciences to Host Conference Call and Webcast to Discuss Results for the Fourth Quarter and Full Year 2021 and Corporate Update
ATAI Life Sciences
Clearmind Medicine to Partner with Microdose for Psychedelic Capital: Mar 2022 on Thursday, March 24th
Clearmind Medicine
NeonMind Unveils Initial Treatment Offering at Specialty Mental Health Clinic in Mississauga
NeonMind Biosciences Inc.
Tryp Therapeutics Initiates Enrollment for Binge Eating Disorder Study in Partnership with University of Florida
Tryp Therapeutics
Universal Ibogaine Expands Research Team With Julie Dumouchel, Director Of Clinical Trials
Universal Ibogaine
Filament Health Announces Second Patent Issuance
Filament Health
PsyBio Therapeutics to Participate in the 2022 Maxim Group Virtual Growth Conference on March 28-30, 2022
PsyBio Therapeutics
Nova Mentis Begins Enrollment in North American Autism Study
Nova Mentis Life Science
NeonMind Announces Positive Preclinical Results Demonstrating the Efficacy of Psilocybin in Reducing Weight Gain in Obese Animal Subjects
NeonMind Biosciences Inc.
Field Trip Health Ltd. to Participate in Maxim Group 2nd Annual Virtual Growth Conference
Field Trip Health
Awakn Life Sciences Announces Closing of Private Placement
Awakn Life Sciences
Wesana Health Announces New Findings Indicating Psylocibin Potentiates Impact of an Anti-Depressant
Wesana Health
Red Light Holland Announces Mushroom Home Grow Kits Produced by Happy Caps Mushroom Farm Are Now Available for Purchase in 30 Retail Stores Across Canada
Red Light Holland
NeonMind Files New Provisional Patent Application Covering Novel Mechanism of Weight Loss
NeonMind Biosciences Inc.
Get the Headlines & Market Updates
Be the first to see new company features, exclusive interviews and breaking news. Subscribe now.